Evidence map›Paper›PMID 37327241›Full record

ArticlePLoS computational biology2023

Whole-cell modeling of E. coli colonies enables quantification of single-cell heterogeneity in antibiotic responses.

Christopher J Skalnik, Sean Y Cheah, Mica Y Yang, Mattheus B Wolff, Ryan K Spangler, Lee Talman, Jerry H Morrison, Shayn M Peirce, Eran Agmon, Markus W Covert

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Data hazards in synthetic biology.Synthetic biology (Oxford, England) · 2024
    Review
  8. Multi-scale models of whole cells: progress and challenges.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Christopher J SkalnikDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-6344-7331
Sean Y CheahDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.
Mica Y YangDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.
Mattheus B WolffDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.
Ryan K SpanglerDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-6080-3142
Lee TalmanDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, United States of America.
Jerry H MorrisonDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.ORCID 0000-0001-9414-6999
Shayn M PeirceDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0001-5857-5606
Eran AgmonDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.ORCID 0000-0003-1279-2474
Markus W CovertDepartment of Bioengineering, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-5993-8912
Stanford University · USUniversity of Virginia · USUniversity of Connecticut · US

Funding

Molecular Biophysics Training Program at StanfordT32GM136568 · NIGMS · STANFORD UNIVERSITY · PI Zev Bryant, KERWYN C. HUANG · 2021 to 2026
$3.7M
Multi-scale, model-driven exploration of sub-generational gene expression in bacteria: individual consequences, population benefitsR01GM140008 · NIGMS · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2021 to 2024
$2.2M
Deep Curation via an Integrated Whole-Cell Computational ModelR01LM013229 · NLM · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2020 to 2023
$1.5M
Adding an environment and motility in a Whole Cell Model of Escherichia ColiF32GM137464 · NIGMS · STANFORD UNIVERSITY · PI AGMON, ERAN · 2020 to 2021
$138k
NIGMS NIH HHS F32 GM137464NIGMS NIH HHS R01 GM140008NIGMS NIH HHS T32 GM136568NLM NIH HHS R01 LM013229
6 · The paper itself

Abstract

Antibiotic resistance poses mounting risks to human health, as current antibiotics are losing efficacy against increasingly resistant pathogenic bacteria. Of particular concern is the emergence of multidrug-resistant strains, which has been rapid among Gram-negative bacteria such as Escherichia coli. A large body of work has established that antibiotic resistance mechanisms depend on phenotypic heterogeneity, which may be mediated by stochastic expression of antibiotic resistance genes. The link between such molecular-level expression and the population levels that result is complex and multi-scale. Therefore, to better understand antibiotic resistance, what is needed are new mechanistic models that reflect single-cell phenotypic dynamics together with population-level heterogeneity, as an integrated whole. In this work, we sought to bridge single-cell and population-scale modeling by building upon our previous experience in "whole-cell" modeling, an approach which integrates mathematical and mechanistic descriptions of biological processes to recapitulate the experimentally observed behaviors of entire cells. To extend whole-cell modeling to the "whole-colony" scale, we embedded multiple instances of a whole-cell E. coli model within a model of a dynamic spatial environment, allowing us to run large, parallelized simulations on the cloud that contained all the molecular detail of the previous whole-cell model and many interactive effects of a colony growing in a shared environment. The resulting simulations were used to explore the response of E. coli to two antibiotics with different mechanisms of action, tetracycline and ampicillin, enabling us to identify sub-generationally-expressed genes, such as the beta-lactamase ampC, which contributed greatly to dramatic cellular differences in steady-state periplasmic ampicillin and was a significant factor in determining cell survival.

Indexed as

Anti-Bacterial AgentsEscherichia coliAmpicillinBacteriabeta-LactamasesDrug Resistance, MicrobialHumansMicrobial Sensitivity TestsTetracyclineAmpicillinAnti-Bacterial Agentsbeta-LactamasesTetracycline

Identifiers

PMID37327241
PMCPMC10310025
OpenAlexW4380988061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.